Compliance to live oral Ty21a typhoid vaccine, and its effect on viability

Journal of Travel Medicine

Volumn 7, Issue 3, 2000, Pages 133-137

  Fallab Stubi, Claire Lise ^a   Landry, Pierre R ^a   Pétignat, Christine ^b   Bille, Jacques ^b   Genton, Blaise ^a   Darioli, Roger ^a   Burnier, Michel ^a  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TYPHOID VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG STORAGE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TRAVEL;

EID: 0343893725     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2000.00044     Document Type: Article

References (28)

1. Swiss Federal Office of Public Health. Fièvre typhoide et paratyphoide en Suisse 1988-1992. Bulletin de l'Office Fédéral de la Santé Publique 1993; 46:843-885.
2. Swiss Federal Office of Public Health, ed. Maladies infectieuses en Suisse 1997. Bern, Switzerland: Office Fédéral de la Santé Publique, 1999:5.
3. Reid D, Keystone JS. Health risks aboard : general considerations. In : Dupont HL, Steffen R, eds. Textbook of Travel Medicine and Health, Hamilton, Ontario : B.C. Decker Inc., 1997:5.
4. Acharya IL, Lowe MU, Thapa R, et al. Prevention of typhoid fever in Nepal with Vi capsular polysaccharide of Salmonella typhi. N Engl J Med 1987; 317:1101-1104.
5. Klugman KP, Gilbertson IT, Koornnof HS, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 1987; 2:1165-1169.
6. Wahdan MH, Serie C, Cerisier Y, et al. A controlled field trial of live Salmonella typhi strain Ty21A oral vaccine against typhoid: three year results. J Infect Dis 1982; 145:292-296.
7. Levine MM, Ferreccio C, Black RE, et al. Progress in vaccines against typhoid fever. Rev Infect Dis 1989; 11(3): S552-S567.
8. Levine MM, Ferreccio C, Black RE, Germanier R. Largescale field trial of Ty21a live oral typhoid vaccine in entericcoated capsule formulation. Lancet 1987; 1(8541):1049-1052.
9. Engels EA, Falagas ME, Lau J, Bennish ML. Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. BMJ 1998; 316:110-116.
10. Hirschel B, Wüthrich R, Somaini B, Steffen R. Inefficacy of the commercial live oral Ty21A vaccine in the prevention of typhoid fever. Eur J Clin Microbiol 1985; June:295-298.
11. Kaplan DT, Hill DR. Compliance with live, oral Ty21A typhoid vaccine. JAMA 1992; 267:1074.
12. Wolfe MS. Precautions with oral live typhoid (Ty21A) vaccine. Lancet 1990; 336:631-632.
13. Cramer JA. Overview of methods to measure and enhance patient compliance. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991:5-7.
14. Rahman S, Barr W, Hilton E. Use of oral typhoid vaccine strain Ty21A in a New York State travel immunization facility. Am J Trop Med Hyg 1993; 48:823.
15. Cryz SJ. Patient compliance in the use of Vivorif Berna® vaccine, typhoid vaccine, live oral Ty21A. J Travel Med 1998; 5:14-17.
16. Sackett DL, Haynes RB, et al. Helping patients follow the treatments you prescribe. In: Clinical epidemiology: a basic science for clinical medecine. 2nd Ed. Boston: Little Brown and Co, 1991:258-261.
17. Kruse W, Weber E. Dynamics of drug regimen compliance-its assessement by microprocessor-based monitoring. Eur J Clin Pharmacol 1990; 38:561-565.
18. Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995; 49(3):321-327.
19. Matsuyama JR, Mason BJ, Jue SG. Pharmacists'interventions using an electronic medication-event monitoring device's adherence data versus pill counts. Ann Pharmacother 1993; 27:851-855.
20. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed ? A novel assessment technique. JAMA 1989; 261(22):3273-3278.
21. Pular T, Kumar S, Tindall H, Feely M. Time to stop counting the tablets. Clin Pharmacol Ther 1989; 46:163-168.
22. Fallab Stubi C-L, Zellweger JP, Sauty A, et al. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Int J Tuberc Lung Dis 1998; 2(7):1-6.
23. McKenney JM, Munroe WP, Wright JT. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992; 32:277-283.
24. Simanjuntak CH, Paleologo FP, Punjabi NH, et al. Oral immunization against tyhpoid fever in Indonesia with Ty 21A vaccine. Lancet 1991; 338:1055-1059.
25. Mullen PD, Green LW, Perstinger GS. Clinical trials of patient education for chronic conditions : a comparative metaanalysis of intervention types. Preventive Medecine 1985; 14:753-781.
26. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 1996; 348:383-386.
27. Rogers HPG, Bullman WR. Prescription medicine compliance : a review of the baseline of knowledge-a report of the national council on patient information and education. J Pharmacoepidemiol 1995; 3(2):3-36.
28. Roter DL, Hall JA, Merisca R, et al. Effectivness of intervention to improve patient compliance, a meta-analysis. Medical Care 1998; 36(8):1138-1161.